Biodiagnostic Labs, INC

Biodiagnostic Labs, INC was paid $2.79M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 52% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New York

Rank by total paid#39 of 116

Median peer was paid$618K

This provider vs. median4.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	30,409	$117K
2019	25,800	$120K
2020	24,444	$733K
2021	39,507	$1.06M
2022	34,911	$675K
2023	11,282	$52K
2024incomplete	10,678	$34K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	52%	21,135	14,174	$1.46M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	15,472	9,633	$313K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	6.4%	2,165	1,348	$178K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.2%	11,034	9,400	$117K
80053	Comprehensive metabolic panel	3.8%	14,061	11,516	$107K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	3.0%	4,937	2,036	$83K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.9%	804	743	$80K
83036	Hemoglobin; glycosylated (A1C)	2.3%	8,058	7,354	$63K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.7%	1,940	1,827	$48K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.7%	18,906	14,122	$47K
84443	Thyroid stimulating hormone (TSH)	1.4%	5,987	5,504	$39K
80048	Basic metabolic panel (calcium, ionized)	1.3%	6,363	4,443	$35K

75 more codes

87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	810	$24K
80164		<1%	2,011	$18K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	6,638	$16K
80177		<1%	1,766	$16K
85610		<1%	4,448	$15K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,038	$13K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	12,829	$13K
80061	Lipid panel	<1%	5,093	$12K
84439		<1%	1,343	$9K
82607		<1%	1,036	$8K
84153		<1%	392	$7K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	5,385	$5K
87077		<1%	534	$5K
87184		<1%	649	$4K
86769		<1%	135	$4K
81001		<1%	1,299	$4K
85027		<1%	1,606	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	72	$4K
82465		<1%	2,553	$3K
82746		<1%	406	$3K
84478		<1%	2,494	$3K
80076		<1%	576	$2K
83718		<1%	2,443	$2K
82947		<1%	1,114	$2K
85048		<1%	818	$2K
84436		<1%	716	$2K
82728		<1%	297	$2K
84480		<1%	806	$1K
86328		<1%	37	$1K
86710		<1%	151	$960.19
83540		<1%	389	$830.76
81003		<1%	468	$689.36
86140		<1%	250	$630.16
87070		<1%	88	$623.42
84132		<1%	174	$568.22
82040		<1%	183	$480.42
83550		<1%	369	$463.88
84466		<1%	66	$433.64
85651		<1%	353	$430.97
83735		<1%	260	$375.86
80185		<1%	46	$367.50
82310		<1%	224	$366.23
82565		<1%	259	$349.99
82140		<1%	31	$314.76
S9529	Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient	<1%	149	$268.20
80202		<1%	26	$231.00
84479		<1%	472	$221.44
87040		<1%	31	$211.90
87634		<1%	44	$203.21
82248		<1%	140	$195.72
84520		<1%	227	$183.51
84075		<1%	118	$172.90
84100		<1%	116	$155.16
84450		<1%	139	$154.93
80051		<1%	31	$146.52
84460		<1%	123	$136.18
84550		<1%	77	$133.40
87449		<1%	31	$132.92
82247		<1%	98	$127.13
87324		<1%	13	$112.80
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	24	$107.96
84155		<1%	115	$96.93
85049		<1%	25	$72.55
85379		<1%	16	$71.26
85730		<1%	16	$68.09
84295		<1%	65	$65.01
85014		<1%	50	$65.00
85018		<1%	50	$62.00
82374		<1%	63	$57.91
83615		<1%	57	$54.61
85041		<1%	25	$53.55
82435		<1%	51	$49.15
84134		<1%	14	$43.92
82150		<1%	18	$26.69
36415	Collection of venous blood by venipuncture	<1%	90	$14.64

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSONTAG, GERSHON (PRESIDENT)